Minute Insight: AbbVie Bets Big On Glaucoma Market With iSTAR Purchase Deal
Executive Summary
The pharmaceutical company has made a bold play to expand its presence in the device space, giving iSTAR upfront cash in a deal that grants it the right to buy iSTAR for almost half a billion dollars.
You may also be interested in...
Deals Shaping The Medical Industry, July 2022
In Vivo's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in July 2022. Data provided by Biomedtracker.
Deals Shaping The Medtech And Diagnostics Industry, July 2022
Medtech Insight's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics and Medical Devices – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in July 2022. Data provided by Biomedtracker.
Minute Insight: iSTAR Medical Receives CE Mark For Glaucoma Device
MINIject has been approved in Europe for open-angle glaucoma patients.